Showing results (1701-1710 of 1,739) with videos related to
Sort By:
Pageof 174
Science Translational Medicine|January 25, 2019
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui, et al.European Urology|January 15, 2016
Role of Human Papillomavirus in Penile Carcinomas WorldwideLaia Alemany, Antonio Cubilla, Gordana Halec, et al.Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|January 10, 2023
Sociodemographic characteristics, comorbidity, and baseline functional status of older patients treated in emergency departments during the COVID-19 pandemic and associations with mortality: an analysis based on the EDENCOVID cohortJuan González Del Castillo, Javier Jacob, Eric Jorge García-Lamberechts, et al.NAR Cancer|March 10, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatmentRoderic Espín, Ferran Medina-Jover, Javier Sigüenza-Andrade, et al.Lancet (London, England)|August 11, 2022
Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort studyEloy José Tarín-Vicente, Andrea Alemany, Manuel Agud-Dios, et al.The New England Journal of Medicine|December 8, 2020
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19Oriol Mitjà, Marc Corbacho-Monné, Maria Ubals, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2020
Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled TrialOriol Mitjà, Marc Corbacho-Monné, Maria Ubals, et al.The Lancet. Respiratory Medicine|February 12, 2022
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trialAndrea Alemany, Pere Millat-Martinez, Marc Corbacho-Monné, et al.Nature Communications|October 13, 2021
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancerAida Ferreiro-Iglesias, James D McKay, Nicole Brenner, et al.Journal of the National Cancer Institute|September 5, 2024
Understanding risk factors for endometrial cancer in young womenNoah Charles Peeri, Kimberly A Bertrand, Renhua Na, et al.Pageof 174